Literature DB >> 19224637

CD152 (CTLA-4) regulates effector functions of CD8+ T lymphocytes by repressing Eomesodermin.

Johannes K Hegel1, Karin Knieke, Paula Kolar, Steven L Reiner, Monika C Brunner-Weinzierl.   

Abstract

CD8(+) T lymphocytes are required for effective host defense against pathogens and also for mediating effector responses against uncontrolled proliferating self-tissues. In this study, we determine that individual CD8(+) T cells are tightly controlled in their effector functions by CD152 (CTLA-4). We demonstrate that signals induced by CD152 reduce the frequency of IFN-gamma and granzyme B expressing CD8(+) T cells independently of the transcription factors T-bet or cKrox by selectively inhibiting accumulation of Eomesodermin mRNA and protein. Ectopic expression of Eomesodermin reversed the CD152-mediated inhibition of effector molecule production. Additionally, enhanced cytotoxicity of individual CD8(+) T cells differentiated in the absence of CD152 signaling was determined in vivo. These novel insights extend our understanding of how immune responses of CD8(+) T cells are selectively modulated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224637     DOI: 10.1002/eji.200838770

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

1.  ICAM-1-dependent homotypic aggregates regulate CD8 T cell effector function and differentiation during T cell activation.

Authors:  Nicholas A Zumwalde; Eisuke Domae; Matthew F Mescher; Yoji Shimizu
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

2.  Eomesodermin(lo) CTLA4(hi) Alloreactive CD8+ Memory T Cells Are Associated With Prolonged Renal Transplant Survival Induced by Regulatory Dendritic Cell Infusion in CTLA4 Immunoglobulin-Treated Nonhuman Primates.

Authors:  Mohamed B Ezzelarab; Lien Lu; Hao Guo; Alan F Zahorchak; William F Shufesky; David K C Cooper; Adrian E Morelli; Angus W Thomson
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

3.  The differentiation and plasticity of Tc17 cells are regulated by CTLA-4-mediated effects on STATs.

Authors:  Aditya Arra; Holger Lingel; Benno Kuropka; Jonas Pick; Tina Schnoeder; Thomas Fischer; Christian Freund; Mandy Pierau; Monika C Brunner-Weinzierl
Journal:  Oncoimmunology       Date:  2017-01-20       Impact factor: 8.110

4.  Activation of the Hippo pathway by CTLA-4 regulates the expression of Blimp-1 in the CD8+ T cell.

Authors:  James E D Thaventhiran; Anja Hoffmann; Lukasz Magiera; Maike de la Roche; Holger Lingel; Monika Brunner-Weinzierl; Douglas T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-27       Impact factor: 11.205

5.  Associations between cytotoxic T lymphocyte-associated antigen-4 polymorphisms and serum tumor necrosis factor-α and interferon-γ levels in patients with chronic hepatitis B virus infection.

Authors:  Qunying Han; Shaoqiong Duan; Guoyu Zhang; Zhu Li; Na Li; Qianqian Zhu; Yi Lv; Jinghong Chen; Zhengwen Liu
Journal:  Inflamm Res       Date:  2011-08-17       Impact factor: 4.575

Review 6.  Memories that last forever: strategies for optimizing vaccine T-cell memory.

Authors:  Jeffrey D Ahlers; Igor M Belyakov
Journal:  Blood       Date:  2009-11-10       Impact factor: 22.113

7.  Ipilimumab reshapes T cell memory subsets in melanoma patients with clinical response.

Authors:  Joana Felix; Jérome Lambert; Marie Roelens; Eve Maubec; Hélène Guermouche; Cécile Pages; Irina Sidina; Debora J Cordeiro; Guitta Maki; François Chasset; Raphaël Porcher; Martine Bagot; Anne Caignard; Antoine Toubert; Céleste Lebbé; Hélène Moins-Teisserenc
Journal:  Oncoimmunology       Date:  2016-02-18       Impact factor: 8.110

8.  CTLA-4 co-receptor impacts on the function of Treg and CD8+ T-cell subsets.

Authors:  Christopher E Rudd
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

9.  Impairments in Peripheral Blood T Effector and T Regulatory Lymphocytes in Bipolar Disorder Are Associated with Staging of Illness and Anti-cytomegalovirus IgG Levels.

Authors:  Michael Maes; Joao Victor Nani; Cristiano Noto; Lucas Rizzo; Mirian A F Hayashi; Elisa Brietzke
Journal:  Mol Neurobiol       Date:  2020-09-11       Impact factor: 5.590

Review 10.  Betting on immunotherapy for melanoma.

Authors:  Mario Sznol
Journal:  Curr Oncol Rep       Date:  2009-09       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.